For cystic fibrosis (CF) patients, the benefits of elexacaftor-tezacaftor-ivacaftor (ETI; Trikafta) may extend to relief from chronic rhinosinusitis, a small cohort study suggested. After a year of ...
Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis. Murray et al, Eur Respir J 2009, DOI: 10.1183/09031936.00163208 Colour of phlegm can predict outcomes for patients with the ...
People with cystic fibrosis (CF) face persistent threats from pathogens including Pseudomonas aeruginosa (Pa), which grow in the lung’s mucus-clogged environment. Detecting these infections early is ...
Non–cystic fibrosis bronchiectasis (NCFB) is a chronic inflammatory condition of the lungs associated with respiratory infections and daily cough and sputum. Non-cystic fibrosis bronchiectasis. Image ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results